Biologic injections at home, preparing kids & adults for success (not quitting Tx)

Share on facebook
Share on twitter
Share on linkedin

Filmed live at the Hive, Atlanta, Georgia, on October 14, 2020. Dr. Baxter discusses how to be successful with a new biologic regimen at home. Dupixent, newly indicated to treat kids age 6+ with eczema, is the example. Dr. Baxter proposes a success strategy based on her Pain-Fear-Focus triad.

 

Today’s focus is on a new medication for DUPIXENT® (dupilumab) – newly indicated to treat people age 6+ with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies.

 

Rituals may be very helpful. Injectables/biologics tend to be viscous, thick, and burning compared to a typical shot. Dr. Baxter covers her Pain-Fear-Focus triad.

 

Setting expectations about an at-home biologic regimen may promote success. We know that 60 – 70% of people prescribed a biologic medication ultimately stop the treatment.

 

30 Million kids are now getting shots at home to treat conditions like . . . juvenile arthritis, asthma, rheumatoid arthritis, diabetes, eczema, psoriasis, Crohn’s disease, ulcerative colitis. And more!

 

Buzzy and VibraCool are FDA registered 510(k) cleared to Control pain associated with injections, venipuncture, IV starts, cosmetic injections and the temporary relief of minor injuries (muscle or tendon aches, splinters and bee stings). Also intended to treat myofascial pain caused by trigger points, restricted motion and muscle tension.

 

Dr. Amy Baxter, MD, bio & more pain relief options here: https://paincarelabs.com/resources/power-over-pain/ 

 

Dr. Amy Baxter directs innovation, invention, and strategy for Pain Care Labs. Accomplishments include international thought leadership on pain management and acute opioid reduction, multiple NIH SBIR Fast-Tracks, eight issued patents, multiple first author textbook chapters and journal publications, and successful 510K FDA clearances. After graduating from Yale University and Emory Medical School, as a double-boarded pediatric emergency physician, Dr. Baxter founded PEMA Emergency Research, created and validated the BARF pediatric nausea scale cited in fifty studies, and founded Pain Care Labs. Recognition includes Forbes Ten Healthcare Disruptors, Inc. Top Women in Tech to Watch, Top 10 Innovative and Disruptive Women in Healthcare, a Wall Street Journal “Idea Person”, and the Most Innovative CEO of 2014 from Georgia Bio. National and international lecturing highlights include MakerFaire, AARP, and TEDMED. On Homeolux Board of Directors. Also known for turning down Mr. Wonderful on Shark Tank.